Oral Contraceptives and Myocardial Infarction

Abstract
Present knowledge of the risks and benefits of oral contraceptives has recently been extended in a report from a prospective study by Vessey et al.1 Women who used oral contraceptives at the start of the study later experienced an excess of hospital referrals for cerebrovascular disease, cervical erosion, skin disorders, self-poisoning, migraine, venous thrombosis and embolism, hay fever, gallbladder disease, amenorrhea and sterility; they showed fewer than expected hospital referrals for cancer, benign lesions of the breast, menstrual disorders other than amenorrhea, duodenal ulcer and retention cysts of the ovary. Clearly, more data are needed before conclusions can be drawn . . .